Company page
Corvus Pharmaceuticals, Inc.
Corvus Pharmaceuticals, Inc. (ticker: CRVS) is a public company based in America with a market capitalization of approximately $1 billion. The company focuses on developing innovative therapies for cancer treatment. Corvus aims to address unmet medical needs in oncology through its research and development efforts.
- Ticker
- CRVS:NASDAQ
- Asset type
- Stock
- Market cap
- $1.00B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD